Molecular Devices’ RNAi and High Content Imaging Symposium
News Sep 14, 2010
The RNAi and High Content Imaging Symposium will be discussed at a one day symposium to be held at The Burlington Hotel, Dublin, Ireland, September 16, 2010. The symposium follows the RNAi & miRNA Europe Conference.
Registration is now open for Molecular Devices’ RNAi and High Content Imaging Symposium. Join influential and respected scientists to discuss the expansion of RNAi profiling techniques and how to enhance gene expression assays using high content imaging systems. The preliminary agenda includes presentations by:
• Session Chair: Dr. Anthony Davies, Trinity College Dublin
• Dr. Nick Holliday, University of Nottingham
• Dr. Stephen Brown, University of Sheffield
• Dr. Randi Diestel, Helmholtz Centre for Infection Research GmbH
• Dr. Alan Sabirsh, AstraZeneca, Södertälje, Sweden
Additional user-presentations will focus on RNAi profiling techniques, tips and tricks for interrogating large-scale RNAi libraries as well as automated data analysis and integration. Do not miss this opportunity to join your industry colleagues…
Registration for this event is free of charge. Attendance will be limited, so please register early for this event.
Refreshments and a buffet lunch will be served during the symposium.
For further information on Molecular Devices’ RNAi and High Content Imaging Symposium, please email firstname.lastname@example.org.
Potential Barcode Identified for a Form of Alcoholic Liver DiseaseNews
NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.READ MORE
RNA Molecules Lives Are 10 Times Shorter Than Previously ThoughtNews
A research group at the Biozentrum of the University of Basel has developed a new method to measure the half-life of RNA molecules.READ MORE
Changing microRNA's Presence in Glioblastoma Cells Could Change the Tumor's SubtypeNews
BWH researchers examined a specific microRNA, miR-128, to help identify glioblastoma subtypes and to determine if altering the microRNA's presence in glioblastoma cells could change the tumor's subtype.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018